Coronary bioresorbable vascular scaffold radiopaque marker embolization.
Department of Cardiology, Academic Medical Center, University of Amsterdam. Meibergdreef 9, 1105 AZ, Amsterdam.
Carlos
C
Collet
Department of Cardiology, Academic Medical Center, University of Amsterdam. Meibergdreef 9, 1105 AZ, Amsterdam.
Pannipa
P
Suwannasom
Department of Cardiology, Hospital Santa Cruz, Av. Prof. Dr. Reinaldo dos Santos, 2790-134 Carnaxide, Portugal.
Manuel
M
Almeida
Cardialysis BV, Rotterdam. Westblaak 98, entrance B, 6th floor, 3012 KM Rotterdam, The Netherlands.
Yoshinobu
Y
Onuma
Department of Cardiology, Imperial College of London. Kensington, London SW7 2AZ, UK.
Patrick W
PW
Serruys
D020341:Absorbable Implants / Q000009:adverse effects*; D003287:Contrast Media / Q000009:adverse effects*; D004617:Embolism / Q000139:chemically induced*; D000068338:Everolimus / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D062645:Percutaneous Coronary Intervention; D054457:Tissue Scaffolds / Q000009:adverse effects*
D003287:Contrast Media; D007166:Immunosuppressive Agents; D000068338:Everolimus